Literature DB >> 9114031

Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder.

M Karayiorgou1, M Altemus, B L Galke, D Goldman, D L Murphy, J Ott, J A Gogos.   

Abstract

In the present study, we address the role of the gene for catechol-O-methyltransferase (COMT), a key modulator of dopaminergic and noradrenergic neurotransmission, in the genetic predisposition to obsessive-compulsive disorder (OCD). We show that a common functional allele of this gene, which results in a 3- to 4-fold reduction in enzyme activity, is significantly associated in a recessive manner with susceptibility to OCD, particularly in males. This association is further supported by psychiatric evaluation of patients who carry microdeletions encompassing the comt gene. The mechanism underlying this sex-selective association remains to be defined and may include a sexual dimorphism in COMT activity, although close linkage with a nearby disease susceptibility locus cannot be excluded at this point.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114031      PMCID: PMC20764          DOI: 10.1073/pnas.94.9.4572

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Antiandrogenic treatment of obsessive-compulsive neurosis.

Authors:  M Casas; E Alvarez; P Duro; C Garcia-Ribera; C Udina; A Velat; D Abella; J Rodriguez-Espinosa; P Salva; F Jané
Journal:  Acta Psychiatr Scand       Date:  1986-02       Impact factor: 6.392

2.  Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.

Authors:  H M Lachman; B Morrow; R Shprintzen; S Veit; S S Parsia; G Faedda; R Goldberg; R Kucherlapati; D F Papolos
Journal:  Am J Med Genet       Date:  1996-09-20

3.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

4.  Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.

Authors:  E Acquas; E Carboni; R H de Ree; M Da Prada; G Di Chiara
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

5.  Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder.

Authors:  B Gutiérrez; J Bertranpetit; R Guillamat; V Vallès; M J Arranz; R Kerwin; L Fañanás
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

6.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

7.  Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.

Authors:  H L McLeod; L Fang; X Luo; E P Scott; W E Evans
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

8.  A family study of obsessive-compulsive disorder.

Authors:  D L Pauls; J P Alsobrook; W Goodman; S Rasmussen; J F Leckman
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

Review 9.  Effects of testosterone and its metabolites on aromatase-immunoreactive cells in the quail brain: relationship with the activation of male reproductive behavior.

Authors:  J Balthazart; A Foidart; P Absil; N Harada
Journal:  J Steroid Biochem Mol Biol       Date:  1996-01       Impact factor: 4.292

10.  Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2.

Authors:  A E Pulver; M Karayiorgou; V K Lasseter; P Wolyniec; L Kasch; S Antonarakis; D Housman; H H Kazazian; D Meyers; G Nestadt
Journal:  Am J Med Genet       Date:  1994-03-15
View more
  46 in total

Review 1.  The genetics of obsessive-compulsive disorder.

Authors:  M T Pato; K M Schindler; C N Pato
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

2.  Identification of a novel haplotype of the human catechol-O-methyltransferase gene.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

3.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

4.  Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.

Authors:  B Meyers; A D'Agostino; J Walker; M F Kritzer
Journal:  Neuroscience       Date:  2009-11-10       Impact factor: 3.590

5.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.

Authors:  J A Gogos; M Morgan; V Luine; M Santha; S Ogawa; D Pfaff; M Karayiorgou
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 6.  A biologic model to study the genetics of psychotic, mood, and anxiety disorders: the velocardiofacial syndrome.

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

Review 7.  The genetic studies of obsessive-compulsive disorder and its future directions.

Authors:  Se Joo Kim; Chan-Hyung Kim
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

8.  Associations between the COMT Val/Met polymorphism, early life stress, and personality among healthy adults.

Authors:  Karin F Hoth; Robert H Paul; Leanne M Williams; Carol Dobson-Stone; Elizabeth Todd; Peter R Schofield; John Gunstad; Ronald A Cohen; Evian Gordon
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

9.  Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.

Authors:  Andrea G Nackley; Svetlana A Shabalina; Jason E Lambert; Mathew S Conrad; Dustin G Gibson; Alexey N Spiridonov; Sarah K Satterfield; Luda Diatchenko
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.